Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2011, Article ID 830434, 6 pages
http://dx.doi.org/10.4061/2011/830434
Clinical Study

Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study

Department of Internal Medicine, School of Medicine University of Ioannina, 45 110 Ioannina, Greece

Received 13 February 2011; Accepted 11 March 2011

Academic Editor: Samy I. McFarlane

Copyright © 2011 Anastazia Kei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • Anastazia Kei, and Moses S. Elisaf, “Nicotinic acid: clinical considerations,” Expert Opinion On Drug Safety, vol. 11, no. 4, pp. 551–564, 2012. View at Publisher ยท View at Google Scholar
  • Anastazia Kei, “Nicotinic acid: Do we know how it works after 55 years of clinical experience,” World Journal of Pharmacology, vol. 1, no. 3, pp. 50, 2012. View at Publisher ยท View at Google Scholar
  • Heiner K. Berthold, and Ioanna Gouni-Berthold, “The Role of Niacin in Lipid-lowering Treatment: Are we Aiming Too High?,” Current Pharmaceutical Design, vol. 19, no. 17, pp. 3094–3106, 2013. View at Publisher ยท View at Google Scholar
  • A. Kei, E. N. Liberopoulos, D. P. Mikhailidis, and M. Elisaf, “Comparison of switch to the highest dose of rosuvastatin vs. add-on nicotinic acid vs. add-on fenofibrate for mixed dyslipidaemia,” International Journal Of Clinical Practice, vol. 67, no. 5, pp. 412–419, 2013. View at Publisher ยท View at Google Scholar
  • Anastazia Kei, and Moses Elisaf, “Nicotinic acid/laropiprant reduces platelet count but increases mean platelet volume in patients with primary dyslipidemia,” Archives of Medical Science, vol. 10, no. 3, pp. 439–444, 2014. View at Publisher ยท View at Google Scholar
  • Konstantinos Tziomalos, Asterios Karagiannis, and Vasilios G. Athyros, “Effects of lipid-lowering agents on inflammation, haemostasis and blood pressure,” Current Pharmaceutical Design, vol. 20, no. 40, pp. 6306–6313, 2014. View at Publisher ยท View at Google Scholar
  • Theodosios D. Filippatos, and Moses S. Elisaf, “Recommendations for severe hypertriglyceridemia treatment, are there new strategies?,” Current Vascular Pharmacology, vol. 12, no. 4, pp. 598–616, 2014. View at Publisher ยท View at Google Scholar
  • Aris P. Agouridispp. 37–43, 2015. View at Publisher ยท View at Google Scholar